Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC）

This study is using medical imaging and tissue analysis to predict how well non-small cell lung cancer (NSCLC) patients will respond to neoadjuvant therapy — treatment given before surgery to shrink the tumor. The goal is to find biomarkers that can identify which patients are most likely to benefit from pre-surgical treatment. **You may be eligible if...** - You have been diagnosed with non-small cell lung cancer confirmed by pathology - Your treatment plan includes neoadjuvant chemo-immunotherapy followed by surgical removal of the tumor **You may NOT be eligible if...** - Your lung cancer has returned after previous treatment (recurrent) or has spread to other organs (metastatic) - You have another primary cancer in addition to lung cancer Talk to your doctor to see if this trial is right for you.